KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Cash from Operations (2016 - 2025)

Historic Cash from Operations for Globus Medical (GMED) over the last 15 years, with Q3 2025 value amounting to $249.7 million.

  • Globus Medical's Cash from Operations rose 2260.75% to $249.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $715.2 million, marking a year-over-year increase of 7234.83%. This contributed to the annual value of $520.6 million for FY2024, which is 11381.53% up from last year.
  • Globus Medical's Cash from Operations amounted to $249.7 million in Q3 2025, which was up 2260.75% from $77.9 million recorded in Q2 2025.
  • In the past 5 years, Globus Medical's Cash from Operations ranged from a high of $249.7 million in Q3 2025 and a low of $32.9 million during Q3 2022
  • For the 5-year period, Globus Medical's Cash from Operations averaged around $90.7 million, with its median value being $63.6 million (2021).
  • In the last 5 years, Globus Medical's Cash from Operations plummeted by 5739.17% in 2022 and then surged by 30340.31% in 2024.
  • Quarter analysis of 5 years shows Globus Medical's Cash from Operations stood at $76.3 million in 2021, then decreased by 16.1% to $64.0 million in 2022, then surged by 63.62% to $104.7 million in 2023, then skyrocketed by 100.95% to $210.3 million in 2024, then rose by 18.71% to $249.7 million in 2025.
  • Its Cash from Operations stands at $249.7 million for Q3 2025, versus $77.9 million for Q2 2025 and $177.3 million for Q1 2025.